Pharmaceutical manufacturer Allergan, Inc. has agreed to pay $600 million to settle a whistleblower claim they paid illegal remuneration to health care providers to induce them to prescribe the company’s products.

The whistleblowers alleged that Allergan implemented a sophisticated marketing plan with the purpose of inducing physicians to prescribe Botox Therapeutic for various off-label uses which were neither FDA-approved nor demonstrated to be safe and effective.

According to the lawsuits, Allergan understood the lack of scientific evidence that Botox was safe for these off-label uses when the company initiated the illegal marketing scheme.

To settle the lawsuit, filed under the False Claims Act, Allergan will pay the federal government $375 million in criminal fines an $210,150,000 for the civil allegations.

If you are a whistleblower with information about fraud on the government, you may be able to bring a Qui Tam lawsuit under the False Claims Act. Please contact the Qui Tam Attorneys of Tycko & Zavareei, LLP, at 202-973-0900 today.